First Scale-Up Synthesis of WAY-262398, a Novel, Dual-Acting SSRI/5HT1a Antagonist.
Autor: | Antonia Nikitenko, Asaf Alimardanov, Jay Afragola, Jean Schmid, Livia Kristofova, Deborah Evrard, Nicole T. Hatzenbuhler, Vasilios Marathias, Gary Stack, Steve Lenicek, John Potoski |
---|---|
Zdroj: | Organic Process Research & Development; Jan2009, Vol. 13 Issue 1, p91-97, 7p |
Databáze: | Supplemental Index |
Externí odkaz: |